2021•Thesis Commons (OSF Preprints)Open access

Do Chloroquine and Hydroxychloroquine Treat COVID-19?

Sanaa Bouchnafati, Bouhmou Ayoub, Reda Bzikha, Bzikha Ilham

Abstract

Chloroquine is an anti-malarial and autoimmune disease drug, which has an anti- viral activity. In vitro, the Chloroquine and Hydroxychloroquine are potent at inhibiting SARS-CoV. Therefore, Chloroquine and Hydroxychloroquine are being studied for their potential treatment of coronavirus disease 2019. Those drugs are now recommended by the FDA, and multiple health organizations. This aims of this review is to explore the efficacy of the chloroquine and hydrochloroquine in the treatment of the novel COVID-19.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Hydroxychloroquine, Chloroquine, Coronavirus disease 2019 (COVID-19), Medicine, Drug, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Pharmacology, Virology